• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体CHCHD2:疾病相关突变、生理功能及当前动物模型

Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.

作者信息

Kee Teresa R, Espinoza Gonzalez Pamela, Wehinger Jessica L, Bukhari Mohammed Zaheen, Ermekbaeva Aizara, Sista Apoorva, Kotsiviras Peter, Liu Tian, Kang David E, Woo Jung-A A

机构信息

USF Health Byrd Alzheimer's Center and Research Institute, Tampa, FL, United States.

Department of Molecular Pharmacology and Physiology, USF Health Morsani College of Medicine, Tampa, FL, United States.

出版信息

Front Aging Neurosci. 2021 Apr 22;13:660843. doi: 10.3389/fnagi.2021.660843. eCollection 2021.

DOI:10.3389/fnagi.2021.660843
PMID:33967741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100248/
Abstract

Rare mutations in the mitochondrial protein coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) are associated with Parkinson's disease (PD) and other Lewy body disorders. CHCHD2 is a bi-organellar mediator of oxidative phosphorylation, playing crucial roles in regulating electron flow in the mitochondrial electron transport chain and acting as a nuclear transcription factor for a cytochrome c oxidase subunit (COX4I2) and itself in response to hypoxic stress. CHCHD2 also regulates cell migration and differentiation, mitochondrial cristae structure, and apoptosis. In this review, we summarize the known disease-associated mutations of CHCHD2 in Asian and Caucasian populations, the physiological functions of CHCHD2, how CHCHD2 mutations contribute to α-synuclein pathology, and current animal models of CHCHD2. Further, we discuss the necessity of continued investigation into the divergent functions of CHCHD2 and CHCHD10 to determine how mutations in these similar mitochondrial proteins contribute to different neurodegenerative diseases.

摘要

线粒体蛋白卷曲螺旋-螺旋-卷曲螺旋-螺旋结构域包含蛋白2(CHCHD2)中的罕见突变与帕金森病(PD)及其他路易体疾病相关。CHCHD2是氧化磷酸化的双细胞器介质,在调节线粒体电子传递链中的电子流以及作为细胞色素c氧化酶亚基(COX4I2)和其自身响应缺氧应激的核转录因子方面发挥关键作用。CHCHD2还调节细胞迁移和分化、线粒体嵴结构及细胞凋亡。在本综述中,我们总结了亚洲和白种人群中已知的与疾病相关的CHCHD2突变、CHCHD2的生理功能、CHCHD2突变如何导致α-突触核蛋白病理改变以及当前CHCHD2的动物模型。此外,我们讨论了持续研究CHCHD2和CHCHD10不同功能的必要性,以确定这些相似的线粒体蛋白中的突变如何导致不同的神经退行性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b81/8100248/8a86d7e146f2/fnagi-13-660843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b81/8100248/ebabd2bd59d2/fnagi-13-660843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b81/8100248/8a86d7e146f2/fnagi-13-660843-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b81/8100248/ebabd2bd59d2/fnagi-13-660843-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b81/8100248/8a86d7e146f2/fnagi-13-660843-g002.jpg

相似文献

1
Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.线粒体CHCHD2:疾病相关突变、生理功能及当前动物模型
Front Aging Neurosci. 2021 Apr 22;13:660843. doi: 10.3389/fnagi.2021.660843. eCollection 2021.
2
PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.PD 相关的 CHCHD2 突变会损害 CHCHD10 和 MICOS 复合物,导致线粒体功能障碍。
Hum Mol Genet. 2019 Apr 1;28(7):1100-1116. doi: 10.1093/hmg/ddy413.
3
Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.表达 PD 相关 CHCHD2-T61I 突变的新型小鼠模型的病理特征。
Hum Mol Genet. 2022 Nov 28;31(23):3987-4005. doi: 10.1093/hmg/ddac083.
4
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.CHCHD10 参与由 CHCHD2 功能丧失突变 p.T61I 引起的帕金森病的发病机制。
Neurobiol Aging. 2019 Mar;75:38-41. doi: 10.1016/j.neurobiolaging.2018.10.020. Epub 2018 Oct 23.
5
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.双 CHCH 蛋白,CHCHD2 和 CHCHD10:帕金森病、肌萎缩侧索硬化症和额颞叶痴呆的关键分子。
Int J Mol Sci. 2019 Feb 20;20(4):908. doi: 10.3390/ijms20040908.
6
Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.线粒体 CHCHD2 和 CHCHD10:在神经疾病中的作用和治疗意义。
Neuroscientist. 2020 Apr;26(2):170-184. doi: 10.1177/1073858419871214. Epub 2019 Sep 16.
7
CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.CHCHD2 和 CHCHD10 调节线粒体动力学和综合应激反应。
Cell Death Dis. 2022 Feb 16;13(2):156. doi: 10.1038/s41419-022-04602-5.
8
Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.线粒体 CHCHD 蛋白:生理功能与神经退行性疾病的关联。
Mol Neurobiol. 2017 Sep;54(7):5534-5546. doi: 10.1007/s12035-016-0099-5. Epub 2016 Sep 8.
9
CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in and models of Parkinson's disease.CHCHD2基因Thr61Ile突变在帕金森病的细胞和动物模型中损害F1F0 - ATP合酶组装。
Neural Regen Res. 2024 Jan;19(1):196-204. doi: 10.4103/1673-5374.378010.
10
Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?与神经退行性变相关的线粒体蛋白CHCHD2和CHCHD10——二者有何区别?
Front Cell Dev Biol. 2022 Sep 9;10:996061. doi: 10.3389/fcell.2022.996061. eCollection 2022.

引用本文的文献

1
Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function.二甲双胍改变与线粒体相关的代谢并增强人类少突胶质细胞功能。
Nat Commun. 2025 Aug 30;16(1):8126. doi: 10.1038/s41467-025-63279-4.
2
The mitochondrial intermembrane space - a permanently proteostasis-challenged compartment.线粒体膜间隙——一个蛋白质稳态持续面临挑战的区室。
Biol Chem. 2025 May 27. doi: 10.1515/hsz-2025-0108.
3
LncRNA MALAT1 Facilitates HIV-1 Replication by Upregulation of CHCHD2 and Downregulation of IFN-I Expression.长链非编码RNA MALAT1通过上调CHCHD2和下调I型干扰素表达促进HIV-1复制。

本文引用的文献

1
Early death of ALS-linked CHCHD10-R15L transgenic mice with central nervous system, skeletal muscle, and cardiac pathology.与肌萎缩侧索硬化症相关的CHCHD10-R15L转基因小鼠出现中枢神经系统、骨骼肌和心脏病变并过早死亡。
iScience. 2021 Jan 18;24(2):102061. doi: 10.1016/j.isci.2021.102061. eCollection 2021 Feb 19.
2
Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.CHCHD2基因敲除小鼠中的稳态p62水平及包涵体形成
Hum Mol Genet. 2021 Apr 30;30(6):443-453. doi: 10.1093/hmg/ddab057.
3
MPTP-induced mouse model of Parkinson's disease: A promising direction of therapeutic strategies.
Mol Cell Proteomics. 2025 May 23;24(7):100997. doi: 10.1016/j.mcpro.2025.100997.
4
Genetic Sketch of Parkinson's Disease in India.印度帕金森病的基因概述。
Ann Indian Acad Neurol. 2025 Jul 1;28(4):495-504. doi: 10.4103/aian.aian_1021_24. Epub 2025 May 7.
5
Single cell transcriptome analysis of the THY-Tau22 mouse model of Alzheimer's disease reveals sex-dependent dysregulations.阿尔茨海默病THY-Tau22小鼠模型的单细胞转录组分析揭示了性别依赖性失调。
Cell Death Discov. 2024 Mar 7;10(1):119. doi: 10.1038/s41420-024-01885-9.
6
CHCHD2 up-regulation in Huntington disease mediates a compensatory protective response against oxidative stress.亨廷顿病中 CHCHD2 的上调介导了对氧化应激的代偿性保护反应。
Cell Death Dis. 2024 Feb 10;15(2):126. doi: 10.1038/s41419-024-06523-x.
7
Epigenetic repression of CHCHD2 enhances survival from single cell dissociation through attenuated Rho A kinase activity.通过降低 RhoA 激酶活性,CHCHD2 的表观遗传抑制增强了单细胞解离后的存活能力。
Cell Mol Life Sci. 2024 Jan 12;81(1):38. doi: 10.1007/s00018-023-05060-8.
8
D130A variant on Parkinson 22-related CHCHD2 is predicted to have decreased protein movement.帕金森病22相关的CHCHD2上的D130A变体预计会减少蛋白质运动。
MicroPubl Biol. 2023 Dec 22;2023. doi: 10.17912/micropub.biology.001093. eCollection 2023.
9
INPP5D regulates inflammasome activation in human microglia.INPP5D 调控人小胶质细胞中的炎性体激活。
Nat Commun. 2023 Nov 29;14(1):7552. doi: 10.1038/s41467-023-42819-w.
10
Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.帕金森病中的线粒体功能障碍——具有治疗潜力的关键疾病标志。
Mol Neurodegener. 2023 Nov 11;18(1):83. doi: 10.1186/s13024-023-00676-7.
MPTP 诱导的帕金森病小鼠模型:治疗策略的有前途方向。
Bosn J Basic Med Sci. 2021 Aug 1;21(4):422-433. doi: 10.17305/bjbms.2020.5181.
4
Mitochondrial Nuclear Retrograde Regulator 1 (MNRR1) rescues the cellular phenotype of MELAS by inducing homeostatic mechanisms.线粒体核逆行调节因子 1(MNRR1)通过诱导稳态机制来挽救 MELAS 的细胞表型。
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32056-32065. doi: 10.1073/pnas.2005877117. Epub 2020 Nov 30.
5
Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy.路易体病中的表观遗传学:对基因表达的影响、作为生物标志物的效用,以及治疗的可能性。
Int J Mol Sci. 2020 Jul 2;21(13):4718. doi: 10.3390/ijms21134718.
6
ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.肌萎缩侧索硬化症和帕金森病基因 CHCHD10 和 CHCHD2 修饰人 iPSC 衍生运动神经元中的突触转录组。
Neurobiol Dis. 2020 Jul;141:104940. doi: 10.1016/j.nbd.2020.104940. Epub 2020 May 11.
7
CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.CHCHD10 调节的 OPA1-肌联蛋白复合物介导 TDP-43 诱导的与额颞叶痴呆相关的线粒体表型。
FASEB J. 2020 Jun;34(6):8493-8509. doi: 10.1096/fj.201903133RR. Epub 2020 May 5.
8
Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.CHCHD2和CHCHD10的缺失激活OMA1肽酶,破坏线粒体嵴,模拟患者突变。
Hum Mol Genet. 2020 Jun 3;29(9):1547-1567. doi: 10.1093/hmg/ddaa077.
9
Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro.β淀粉样肽在体外触发α-突触核蛋白聚集。
Molecules. 2020 Jan 29;25(3):580. doi: 10.3390/molecules25030580.
10
Chchd2 regulates mitochondrial morphology by modulating the levels of Opa1.Chchd2 通过调节 Opa1 的水平来调节线粒体形态。
Cell Death Differ. 2020 Jun;27(6):2014-2029. doi: 10.1038/s41418-019-0482-7. Epub 2020 Jan 6.